Can I work with Dr. Sater alongside my own doctor?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Yes. Most people who see Dr. Sater keep their primary care physician, and the arrangement works best when both know what the other is doing. She handles the endocrine and metabolic problem. Your primary physician keeps screening, vaccinations, blood pressure, mental health and everything else. Duplicate lab orders and two people adjusting the same drug are what go wrong.
Yes, and it is the usual arrangement. This is a specialist endocrinology and obesity medicine practice rather than primary care, so most patients keep their existing physician for everything outside that scope. The arrangement holds together when each side knows what the other is doing. It falls apart when two prescribers adjust the same medication, or when the same panel gets drawn twice in a month by two people who have not spoken.
Who does what
The division is usually straightforward. The endocrinologist takes the thyroid, diabetes, insulin resistance, adrenal, pituitary, bone, reproductive hormone and weight management problems, along with the medications attached to them. Your primary care physician keeps the rest: vaccinations, cancer screening, blood pressure and cholesterol management, acute illness, mental health, referrals to other specialties, and the annual overview that no single specialist is positioned to do. Anything on the boundary, such as a statin started for a metabolic reason, is assigned to one of you explicitly rather than assumed.
What your own doctor should receive
Communication is the part that decides whether this works. With your permission, a specialist assessment should reach your primary care physician and should contain the working diagnosis, what was ordered and why, what was prescribed and at what dose, and what is being monitored at what interval. You are entitled to a copy of the same document. If nothing has arrived, ask for it, and take it to your next primary care appointment rather than relying on memory in the room.
The problems worth heading off
Three problems recur. Duplicate lab ordering wastes money and produces results from different assays that are hard to compare, and it is prevented by agreeing who orders the thyroid or metabolic panel. Conflicting dose changes, where two prescribers adjust levothyroxine or a diabetes medication inside the same window, are prevented by naming one prescriber for that drug. And a medication list only one clinician can see is a real hazard with GLP-1 medications, which slow gastric emptying before planned anaesthesia and, in the case of tirzepatide, reduce the efficacy of oral hormonal contraceptives.
| Task | Usually the endocrinologist | Usually your primary care physician |
|---|---|---|
| Thyroid dose adjustment | Yes, while the dose is being titrated | Refills once stable, by agreement |
| Annual review and cancer screening | No | Yes |
| Ordering thyroid and metabolic labs | Yes, while actively adjusting | Yes, once stable |
| Acute illness and urgent problems | No | Yes |
| GLP-1 prescribing and titration | Yes | By agreement once a maintenance dose is reached |
| Mental health treatment | No | Yes, or a psychiatrist |
The concrete step is short. At your next appointment with either physician, ask who is responsible for which medication and which labs, and write the answer down. A virtual specialist also needs you to have a named local physician for anything that requires examination, a procedure or urgent attention, because a video visit cannot examine a neck, perform a diabetic foot check or draw blood.
The clinical detail
Points where co-management most often goes wrong: levothyroxine dose changes made by two prescribers inside one titration window, since TSH is usually rechecked 6 to 8 weeks after a change; thyroid function tests run on different assays, which makes a trend hard to read unless each result travels with its reference range; and biotin containing supplements, which interfere with streptavidin-biotin immunoassays and can distort thyroid results regardless of who ordered them.
With GLP-1 medications the shared items are delayed gastric emptying before planned anaesthesia, reduced efficacy of oral hormonal contraceptives with tirzepatide, and the need to lower insulin or sulfonylurea doses to avoid hypoglycaemia. Each of those belongs on a list your other prescribers can actually see.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Model Policy for the Appropriate Use of Telemedicine Technologies in the Practice of Medicine. Federation of State Medical Boards
- Telehealth policy for providers. U.S. Department of Health and Human Services, telehealth.hhs.gov
- HIPAA and telehealth, Office for Civil Rights guidance. U.S. Department of Health and Human Services
- ZEPBOUND (tirzepatide) injection, prescribing information. U.S. Food and Drug Administration
- Hypothyroidism (Underactive Thyroid). National Institute of Diabetes and Digestive and Kidney Diseases
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.